Jim Simons
CLOV icon

Jim Simons’s Clover Health Investments CLOV Stock Holding History

Jim Simons’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.99M Sell
3,401,541
-1,089,600
-24% -$2.36M 0.01% 1265
2025
Q4 		$10.6M Sell
4,491,141
-3,221,559
-42% -$8.81M 0.02% 891
2025
Q3 		$23.6M Sell
7,712,700
-2,780,900
-27% -$7.94M 0.03% 649
2025
Q2 		$29.3M Sell
10,493,600
-530,800
-5% -$1.75M 0.04% 553
2025
Q1 		$39.6M Sell
11,024,400
-42,200
-0.4% -$169K 0.06% 396
2024
Q4 		$34.9M Sell
11,066,600
-1,413,300
-11% -$5.05M 0.05% 440
2024
Q3 		$35.2M Buy
12,479,900
+1,207,600
+11% +$2.76M 0.05% 444
2024
Q2 		$13.9M Sell
11,272,300
-124,300
-1% -$112K 0.02% 759
2024
Q1 		$9.05M Sell
11,396,600
-1,190,100
-9% -$1.08M 0.01% 1043
2023
Q4 		$12M Buy
12,586,700
+2,179,400
+21% +$2.14M 0.02% 863
2023
Q3 		$11.2M Buy
10,407,300
+1,559,520
+18% +$1.86M 0.02% 860
2023
Q2 		$7.94M Buy
8,847,780
+1,999,380
+29% +$1.77M 0.01% 1152
2023
Q1 		$5.79M Buy
6,848,400
+2,446,000
+56% +$2.68M 0.01% 1389
2022
Q4 		$4.09M Buy
4,402,400
+421,700
+11% +$563K 0.01% 1638
2022
Q3 		$6.77M Buy
3,980,700
+2,351,160
+144% +$6.16M 0.01% 1256
2022
Q2 		$3.49M Buy
1,629,540
+674,740
+71% +$1.79M ﹤0.01% 1810
2022
Q1 		$3.39M Buy
+954,800
New +$2.77M ﹤0.01% 1845

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Jim Simons's CLOV Position: Q1 2026 in Review

Jim Simons reduced its Clover Health Investments (CLOV) stake by 24% in Q1 2026, selling an estimated $2.36M and leaving 3,401,541 shares worth $5.99M. The position accounts for 0.01% of the portfolio, ranked #1265.

Jim Simons first reported a position in CLOV in Q1 2022 and has held it in 17 quarters since. The position peaked at $39.6M in Q1 2025. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • Jim Simons held 3,401,541 shares of Clover Health Investments worth $5.99M as of Q1 2026.
  • Jim Simons sold 1,089,600 Clover Health Investments shares in Q1 2026, an estimated $2.36M.
  • Clover Health Investments made up 0.01% of Jim Simons's portfolio in Q1 2026, its #1265 holding.
  • Jim Simons first reported a position in Clover Health Investments in Q1 2022 and has held it in 17 quarters since.
  • Jim Simons's Clover Health Investments position peaked at $39.6M in Q1 2025.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.